LOCALIZATION OF P-31 MR SIGNAL WITH USE OF SUPERPARAMAGNETIC IRON-OXIDE PARTICLES

被引:3
|
作者
ENGELSTAD, BL
WHITE, DL
MOSELEY, ME
STARK, DD
机构
[1] UNIV CALIF SAN FRANCISCO,SCH MED,DEPT RADIOL,CONTRAST MEDIA LAB,50 S PARNASUS AVE,SAN FRANCISCO,CA 94143
[2] MASSACHUSETTS GEN HOSP,DEPT RADIOL,BOSTON,MA 02114
关键词
Iron; Liver neoplasms; MR studies; 761.1214; Liver; Magnetic resonance (MR); contrast media; experimental; phosphorus studies; spectroscopy;
D O I
10.1148/radiology.176.2.2367662
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
Volume localization of magnetic resonance signals was achieved by using the regional susceptibility differences produced by superparamagnetic iron oxide particles. In vitro experiments demonstrated a direct linear relationship between the concentration of particulate iron and phosphorus-31 chemical shift or line broadening. In vivo experiments indicated that an intravenous dose of 5-10 mg of iron per kilogram of body weight suppressed P-31 signal from normal liver in healthy rats. In rats with hepatic implants of mammary adenocarcinoma, superparamagnetic iron oxide particles suppressed detectable P-31 or hydrogen-1 signal arising from healthy liver tissue, but not that from tumor. Signal due to surface tissues, which affect surface-coil spectra, could be selectively suppressed with a film-based application of particles to the abdominal wall. Thus, P-31 spectra from simulated or actual lesions could be selectively detected after chemically suppressing signals from neighboring or surrounding tissue.
引用
收藏
页码:467 / 472
页数:6
相关论文
共 50 条
  • [1] MR ENHANCEMENT OF HEPATOMA BY SUPERPARAMAGNETIC IRON-OXIDE (SPIO) PARTICLES
    YAMAMOTO, H
    YAMASHITA, Y
    YOSHIMATSU, S
    BABA, Y
    TAKAHASHI, M
    JOURNAL OF COMPUTER ASSISTED TOMOGRAPHY, 1995, 19 (04) : 665 - 667
  • [2] SUPERPARAMAGNETIC IRON-OXIDE PARTICLES - REPLY
    GORE, JC
    MAJUMDAR, S
    RADIOLOGY, 1988, 169 (03) : 657 - 658
  • [3] CARDIOVASCULAR MR IMAGING WITH IRON-OXIDE PARTICLES - UTILITY OF A SUPERPARAMAGNETIC CONTRAST AGENT AND THE ROLE OF DIFFUSION IN SIGNAL LOSS
    ROZENMAN, Y
    ZOU, XM
    KANTOR, HL
    RADIOLOGY, 1990, 175 (03) : 655 - 659
  • [4] SPLENOSIS - SUPERPARAMAGNETIC IRON-OXIDE ENHANCED MR IMAGING
    STORM, BL
    ABBITT, PL
    ALLEN, DA
    ROS, PR
    AMERICAN JOURNAL OF ROENTGENOLOGY, 1992, 159 (02) : 333 - 335
  • [5] INTRAVENOUS MR LYMPHOGRAPHY WITH SUPERPARAMAGNETIC IRON-OXIDE PARTICLES - EXPERIMENTAL STUDIES IN RATS AND RABBITS
    WAGNER, S
    PFEFFERER, D
    EBERT, W
    KRESSE, M
    TAUPITZ, M
    HAMM, B
    LAWACZECK, R
    SEMMLER, W
    WOLF, KJ
    EUROPEAN RADIOLOGY, 1995, 5 (06) : 640 - 646
  • [6] USE OF NEUTRAL SUPERPARAMAGNETIC IRON-OXIDE NANOPARTICLES AS CONTRAST AGENT FOR MR LYMPHOGRAPHY
    DEMARCO, G
    POULIQUEN, D
    PERDRISOT, R
    CHOULY, C
    LEJEUNE, JJ
    JALLET, P
    RADIOLOGY, 1992, 185 : 302 - 302
  • [7] PHARMACOKINETICS OF SUPERPARAMAGNETIC IRON-OXIDE MR CONTRAST AGENTS IN THE RAT
    MAJUMDAR, S
    ZOGHBI, SS
    GORE, JC
    INVESTIGATIVE RADIOLOGY, 1990, 25 (07) : 771 - 777
  • [8] HEPATIC CIRRHOSIS AND HEPATITIS - MR IMAGING ENHANCED WITH SUPERPARAMAGNETIC IRON-OXIDE
    ELIZONDO, G
    WEISSLEDER, R
    STARK, DD
    GUERRA, J
    GARZA, J
    FRETZ, CJ
    TODD, LE
    FERRUCCI, JT
    RADIOLOGY, 1990, 174 (03) : 797 - 801
  • [9] BONE-MARROW - ULTRASMALL SUPERPARAMAGNETIC IRON-OXIDE FOR MR IMAGING
    SENETERRE, E
    WEISSLEDER, R
    JARAMILLO, D
    REIMER, P
    LEE, AS
    BRADY, TJ
    WITTENBERG, J
    RADIOLOGY, 1991, 179 (02) : 529 - 533
  • [10] SUPERPARAMAGNETIC IRON-OXIDE CONTRAST AGENTS IN ABDOMINAL MR-IMAGING
    HAHN, PF
    SAINI, S
    WEISSLEDER, R
    MAYOSMITH, WW
    RADIOLOGY, 1995, 197 : 509 - 509